当前位置: X-MOL 学术Circulation › 论文详情
The Short-Chain Fatty Acid Propionate Protects from Hypertensive Cardiovascular Damage
Circulation ( IF 18.88 ) Pub Date : 2018-12-04 , DOI: 10.1161/CIRCULATIONAHA.118.036652
Hendrik Bartolomaeus, András Balogh, Mina Yakoub, Susanne Homann, Lajos Markó, Sascha Höges, Dmitry Tsvetkov, Alexander Krannich, Sebastian Wundersitz, Ellen G. Avery, Nadine Haase, Kristin Kräker, Lydia Hering, Martina Maase, Kristina Kusche-Vihrog, Maria Grandoch, Jens Fielitz, Stefan Kempa, Maik Gollasch, Zhaxybay Zhumadilov, Samat Kozhakhmetov, Almagul Kushugulova, Kai-Uwe Eckardt, Ralf Dechend, Lars Christian Rump, Sofia K. Forslund, Dominik N. Müller, Johannes Stegbauer, Nicola Wilck

Background: Arterial hypertension and its organ sequelae show characteristics of T cell mediated inflammatory diseases. Experimental anti-inflammatory therapies have been shown to ameliorate hypertensive end-organ damage. Recently, the CANTOS study targeting interleukin-1β demonstrated that anti-inflammatory therapy reduces cardiovascular risk. The gut microbiome plays pivotal role in immune homeostasis and cardiovascular health. Short-chain fatty acids (SCFA) are produced from dietary fiber by gut bacteria and affect host immune homeostasis. Here, we investigated effects of the SCFA propionate in two different mouse models of hypertensive cardiovascular damage.Methods: To investigate the effect of SCFA on hypertensive cardiac damage and atherosclerosis, wild-type NMRI (WT) or ApoE-/- deficient mice received propionate (200mM) or control in the drinking water. To induce hypertension, WT mice were infused with Angiotensin (Ang)II (1.44mg/kg/d s.c.) for 14 days. To accelerate the development of atherosclerosis, ApoE-/- mice were infused with AngII (0.72mg/kg/d s.c.) for 28 days. Cardiac damage and atherosclerosis were assessed using histology, echocardiography, in vivo electrophysiology, immunofluorescence, and flow cytometry. Blood pressure was measured by radiotelemetry. Regulatory T cell (Treg) depletion using PC61 antibody was used to examine the mode of action of propionate.Results: Propionate significantly attenuated cardiac hypertrophy, fibrosis, vascular dysfunction, and hypertension in both models. Susceptibility to cardiac ventricular arrhythmias was significantly reduced in propionate-treated AngII-infused WT mice. Aortic atherosclerotic lesion area was significantly decreased in propionate-treated ApoE-/-. Systemic inflammation was mitigated by propionate treatment, quantified as a reduction in splenic effector memory T cell frequencies and splenic T helper 17 cells in both models, and a decrease in local cardiac immune cell infiltration in WT mice. Cardioprotective effects of propionate were abrogated in Treg-depleted AngII-infused mice, suggesting the effect is Treg-dependent.Conclusions: Our data emphasize an immune-modulatory role of SCFAs and their importance for cardiovascular health. The data suggest that lifestyle modifications leading to augmented SCFA production could be a beneficial non-pharmacological preventive strategy for patients with hypertensive cardiovascular disease.
更新日期:2018-12-04

 

分享到
评论: 0
期刊列表
BMC Chemistry
Nature Pig Research
中山大学化学工程与技术学院诚聘腐蚀与防护相关专业人才
西湖大学邓力教授课题组招聘启事
【问答】请问如何学会分析锂空电池测试中的问题?
天合科研
2017年中科院JCR分区化学大类列表
试剂库存管理
化合物查询
Nature
Nature
nature
down
wechat
bug